|
gptkbp:instanceOf
|
gptkb:chemical_compound
antiprotozoal drug
|
|
gptkbp:administeredBy
|
intramuscular injection
intravenous injection
|
|
gptkbp:ATCCode
|
P01CX01
|
|
gptkbp:CASNumber
|
140-64-7
|
|
gptkbp:contraindication
|
hypersensitivity to pentamidine
|
|
gptkbp:discoveredIn
|
1930s
|
|
gptkbp:eliminatedIn
|
renal
|
|
gptkbp:eliminationHalfLife
|
5-10 hours
|
|
gptkbp:hasMolecularFormula
|
C19H24N4O2·2C2H6O4S
|
|
gptkbp:hasUNII
|
6R8T2G3E8W
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
pentamidine isethionate
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:meltingPoint
|
~166°C (decomposes)
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
390006
DB00738
441356
CHEBI:31962
|
|
gptkbp:sideEffect
|
gptkb:arrhythmia
gptkb:hypoglycemia
pancreatitis
nephrotoxicity
hypotension
hyperglycemia
|
|
gptkbp:synonym
|
gptkb:pentamidine_methanesulfonate
pentamidine dimethanesulfonate
|
|
gptkbp:usedFor
|
treatment of leishmaniasis
treatment of African trypanosomiasis
treatment of Pneumocystis pneumonia
|
|
gptkbp:bfsParent
|
gptkb:pentamidine
|
|
gptkbp:bfsLayer
|
6
|